Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Efgartigimod PH20 SC (VYVGART Hytrulo ) in Patients With Stiff Person Syndrome (SPS): A Double-blind, Placebo-controlled, Cross-over Trial

NCT07860021 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT07860021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07860021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Efgartigimod PH20 SC (VYVGART Hytrulo ) in Patients With Stiff Person Syndrome (SPS): A Double-blind, Placebo-controlled, Cross-over Trial
Lead sponsor
Thomas Jefferson University
Phase
Phase 2/3
Overall status
Recruiting
Start date
September 30, 2026
Completion date
July 31, 2028
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stiff person syndrome